You are here

Article Text

Article menu
Download PDFPDF
Commentary
Adiponectin: a relevant player in obesity-related colorectal cancer?
  1. Antonio La Cava
  1. Correspondence to Professor Antonio La Cava, Department of Medicine, University of California Los Angeles, 1000 Veteran Avenue 32-59, Los Angeles, CA 90095-1670, USA; alacava{at}mednet.ucla.edu

https://doi.org/10.1136/gutjnl-2012-303034

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Obesity is a condition characterised by an abnormally elevated mass of body fat. The past decades have seen a dramatic rise in the worldwide incidence of obesity due to lifestyle changes that have led to an overall reduced physical activity and an increase in the intake of excessive and/or highly caloric or processed foods. As a consequence, obesity represents nowadays a major global health concern. In particular, several epidemiological studies have linked obesity to a shortened lifespan due primarily to a higher risk for the development of chronic pathologies that include cardiovascular complications such as high blood pressure, coronary heart disease and stroke, in addition to insulin resistance and type 2 diabetes.1 Additionally, obesity has also been shown to increase the risk of developing different types of tumours such as the cancer of the oesophagus, colon, rectum, pancreas, gallbladder, kidney, breast, thyroid and endometrium.2

    In obesity, low …

    View Full Text

    Footnotes

    • Funding ALC is supported in part by the NIH grant AI95921.

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles